XML 74 R63.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense $ 10.0 $ 8.4 $ 27.9 $ 17.8
Cost of molecular diagnostic testing        
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense 0.4 0.3 1.1 1.0
Cost of pharmaceutical and clinical services        
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense 0.0 0.1 0.1 0.3
Research and development expense        
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense 0.8 1.3 3.3 3.6
Selling, general, and administrative expense        
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense $ 8.8 $ 6.7 $ 23.4 $ 12.9